{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:50:10Z","timestamp":1751421010369,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10792-021-01708-1","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T12:02:58Z","timestamp":1611403378000},"page":"1479-1485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren\u2019s syndrome versus non-Sjogren\u2019s syndrome"],"prefix":"10.1007","volume":"41","author":[{"given":"Mehmet Ozgur","family":"Cubuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Yucel","family":"Ucgul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armagan","family":"Ozgur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Ozulken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3713-8815","authenticated-orcid":false,"given":"Erdem","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,23]]},"reference":[{"key":"1708_CR1","doi-asserted-by":"publisher","unstructured":"(2007) The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 5(2):75\u201392. https:\/\/doi.org\/10.1016\/s1542-0124(12)70081-2","DOI":"10.1016\/s1542-0124(12)70081-2"},{"issue":"3","key":"1708_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK et al (2017) TFOS DEWS II pathophysiology report. Ocul Surf 15(3):438\u2013510","journal-title":"Ocul Surf"},{"issue":"1","key":"1708_CR3","first-page":"21","volume":"111","author":"T Hikichi","year":"1993","unstructured":"Hikichi T, Yoshida A, Tsubota K (1993) Lymphocytic infiltration of the conjunctiva and the salivary gland in Sjogren\u2019s syndrome. Arch Ophthalmol 111(1):21\u201322","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"1708_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ajo.2013.04.003","volume":"156","author":"SY Lee","year":"2013","unstructured":"Lee SY, Han SJ, Nam SM et al (2013) Analysis of tear cytokines and clinical correlations in Sjogren syndrome dry eye patients and non-Sjogren syndrome dry eye patients. Am J Ophthalmol 156(2):247\u2013253","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1708_CR5","doi-asserted-by":"publisher","first-page":"e0173301","DOI":"10.1371\/journal.pone.0173301","volume":"12","author":"R Liu","year":"2017","unstructured":"Liu R, Gao C, Chen H, Li Y, Jin Y, Qi H (2017) Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease. PLoS ONE 12(4):e0173301","journal-title":"PLoS ONE"},{"issue":"8","key":"1708_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0161-6420(90)32478-8","volume":"97","author":"SC Pflugfelder","year":"1990","unstructured":"Pflugfelder SC, Huang AJ, Feuer W, Chuchovski PT, Pereira IC, Tseng SC (1990) Conjunctival cytologic features of primary Sjogren\u2019s syndrome. Ophthalmology 97(8):985\u2013991","journal-title":"Ophthalmology"},{"issue":"3","key":"1708_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","volume":"19","author":"SC Pflugfelder","year":"1999","unstructured":"Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D (1999) Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren\u2019s syndrome keratoconjunctivitis sicca. Curr Eye Res 19(3):201\u2013211","journal-title":"Curr Eye Res"},{"issue":"2","key":"1708_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-2559.1988.tb02024.x","volume":"13","author":"M Raphael","year":"1988","unstructured":"Raphael M, Bellefqih S, Piette JC, Le Hoang P, Debre P, Chomette G (1988) Conjunctival biopsy in Sjogren\u2019s syndrome: correlations between histological and immunohistochemical features. Histopathology 13(2):191\u2013202","journal-title":"Histopathology"},{"issue":"10","key":"1708_CR9","first-page":"2283","volume":"42","author":"A Solomon","year":"2001","unstructured":"Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC (2001) Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 42(10):2283\u20132292","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1708_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","volume":"26","author":"KC Yoon","year":"2007","unstructured":"Yoon KC, Jeong IY, Park YG, Yang SY (2007) Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 26(4):431\u2013437","journal-title":"Cornea"},{"issue":"1","key":"1708_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ophtha.2014.07.048","volume":"122","author":"P Aragona","year":"2015","unstructured":"Aragona P, Aguennouz M, Rania L et al (2015) Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease. Ophthalmology 122(1):62\u201371","journal-title":"Ophthalmology"},{"key":"1708_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/978-1-4615-5359-5_91","volume":"438","author":"ME Stern","year":"1998","unstructured":"Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC (1998) A unified theory of the role of the ocular surface in dry eye. Adv Exp Med Biol 438:643\u2013651","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"1708_CR13","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0161-6420(86)33528-0","volume":"93","author":"SC Pflugfelder","year":"1986","unstructured":"Pflugfelder SC, Wilhelmus KR, Osato MS, Matoba AY, Font RL (1986) The autoimmune nature of aqueous tear deficiency. Ophthalmology 93(12):1513\u20131517","journal-title":"Ophthalmology"},{"issue":"13","key":"1708_CR14","first-page":"408","volume":"48","author":"Irkec M, Group TOS","year":"2007","unstructured":"Irkec M, Group TOS (2007) Reliability and validity of Turkish translation of the Ocular Surface Disease Index (OSDI) in dry eye syndrome. Invest Ophthalmol Vis Sci 48(13):408\u2013408","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1708_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski SC, Shiboski CH, Criswell L et al (2012) American college of rheumatology classification criteria for sjogren\u2019s syndrome: a data-driven, expert consensus approach in the sjogren\u2019s international collaborative clinical alliance cohort. Arthritis Care Res (Hoboken) 64(4):475\u2013487","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"1708_CR16","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA (2003) Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22(7):640\u2013650","journal-title":"Cornea"},{"issue":"4","key":"1708_CR17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2147\/OPTH.S1409","volume":"2","author":"GD Kymionis","year":"2008","unstructured":"Kymionis GD, Bouzoukis DI, Diakonis VF, Siganos C (2008) Treatment of chronic dry eye: focus on cyclosporine. Clin Ophthalmol 2(4):829\u2013836","journal-title":"Clin Ophthalmol"},{"key":"1708_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4137\/OED.S16067","volume":"6","author":"C Schultz","year":"2014","unstructured":"Schultz C (2014) Safety and efficacy of cyclosporine in the treatment of chronic dry eye. Ophthalmol Eye Dis 6:37\u201342","journal-title":"Ophthalmol Eye Dis"},{"issue":"6","key":"1708_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3341\/kjo.2011.25.6.369","volume":"25","author":"YS Byun","year":"2011","unstructured":"Byun YS, Rho CR, Cho K, Choi JA, Na KS, Joo CK (2011) Cyclosporine 0.05% ophthalmic emulsion for dry eye in Korea: a prospective, multicenter, open-label, surveillance study. Korean J Ophthalmol. 25(6):369\u2013374","journal-title":"Korean J Ophthalmol."},{"issue":"5","key":"1708_CR20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","volume":"107","author":"D Stevenson","year":"2000","unstructured":"Stevenson D, Tauber J, Reis BL (2000) Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology 107(5):967\u2013974","journal-title":"Ophthalmology"},{"issue":"3","key":"1708_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","volume":"13","author":"KH Wan","year":"2015","unstructured":"Wan KH, Chen LJ, Young AL (2015) Efficacy and safety of topical 0.05% Cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf 13(3):213\u2013225","journal-title":"Ocul Surf"},{"issue":"4","key":"1708_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","volume":"107","author":"K Sall","year":"2000","unstructured":"Sall K, Stevenson OD, Mundorf TK, Reis BL (2000) Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 107(4):631\u2013639","journal-title":"Ophthalmology"},{"issue":"4","key":"1708_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3341\/kjo.2018.0116","volume":"33","author":"CH Park","year":"2019","unstructured":"Park CH, Kim MK, Kim EC et al (2019) Efficacy of topical cyclosporine nanoemulsion 0.05% compared with topical cyclosporine emulsion 0.05% and diquafosol 3% in dry eye. Korean J Ophthalmol 33(4):343\u2013352","journal-title":"Korean J Ophthalmol"},{"issue":"11","key":"1708_CR24","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1136\/bjophthalmol-2015-306930","volume":"100","author":"M Straub","year":"2016","unstructured":"Straub M, Bron AM, Muselier-Mathieu A, Creuzot-Garcher C (2016) Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up. Br J Ophthalmol 100(11):1547\u20131550","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"1708_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1080\/09273948.2019.1587470","volume":"28","author":"MJ Kang","year":"2020","unstructured":"Kang MJ, Kim YH, Chou M, Hwang J, Cheon EJ, Lee HJ, Chung SH (2020) Evaluation of the efficacy and safety of a novel 0.05% cyclosporin a topical nanoemulsion in primary Sj\u00f6gren\u2019s syndrome dry eye. Ocul Immunol Inflamm 28(3):370\u2013378. https:\/\/doi.org\/10.1080\/09273948.2019.1587470","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"1708_CR26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2353\/ajpath.2009.090319","volume":"175","author":"GE Katsifis","year":"2009","unstructured":"Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjogren\u2019s syndrome immunopathogenesis. Am J Pathol 175(3):1167\u20131177","journal-title":"Am J Pathol"},{"issue":"4","key":"1708_CR27","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.4049\/jimmunol.181.4.2898","volume":"181","author":"A Sakai","year":"2008","unstructured":"Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S (2008) Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren\u2019s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 181(4):2898\u20132906","journal-title":"J Immunol"},{"issue":"3","key":"1708_CR28","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/art.23214","volume":"58","author":"CQ Nguyen","year":"2008","unstructured":"Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB (2008) Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren\u2019s syndrome: findings in humans and mice. Arthritis Rheum 58(3):734\u2013743","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1708_CR29","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s10792-014-9901-4","volume":"34","author":"H Deveci","year":"2014","unstructured":"Deveci H, Kobak S (2014) The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjogren\u2019s syndrome. Int Ophthalmol 34(5):1043\u20131048","journal-title":"Int Ophthalmol"},{"issue":"5","key":"1708_CR30","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajo.2005.05.025","volume":"140","author":"M Fujita","year":"2005","unstructured":"Fujita M, Igarashi T, Kurai T, Sakane M, Yoshino S, Takahashi H (2005) Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol 140(5):808\u2013813","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"1708_CR31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1167\/iovs.09-3425","volume":"51","author":"KC Yoon","year":"2010","unstructured":"Yoon KC, Park CS, You IC et al (2010) Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Invest Ophthalmol Vis Sci 51(2):643\u2013650","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1708_CR32","first-page":"1356","volume":"41","author":"F Brignole","year":"2000","unstructured":"Brignole F, Pisella PJ, Goldschild M, De Saint JM, Goguel A, Baudouin C (2000) Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 41(6):1356\u20131363","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1708_CR33","first-page":"28","volume":"40","author":"K Tsubota","year":"1999","unstructured":"Tsubota K, Fukagawa K, Fujihara T et al (1999) Regulation of human leukocyte antigen expression in human conjunctival epithelium. Invest Ophthalmol Vis Sci 40(1):28\u201334","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1708_CR34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12891-017-1543-z","volume":"18","author":"SQ Wang","year":"2017","unstructured":"Wang SQ, Zhang LW, Wei P, Hua H (2017) Is hydroxychloroquine effective in treating primary Sjogren\u2019s syndrome: a systematic review and meta-analysis. BMC Musculoskelet Disord 18(1):186","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"1708_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zeron P, Bombardieri S et al (2020) EULAR recommendations for the management of Sjogren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis 79(1):3\u201318","journal-title":"Ann Rheum Dis"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01708-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-01708-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01708-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T18:09:27Z","timestamp":1617991767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-01708-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1708"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-01708-1","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"type":"print","value":"0165-5701"},{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2021,1,23]]},"assertion":[{"value":"12 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Declaration of HELSINKI and its later amendments or comparable ethical standards. Ethical approval was waived by the local Ethics Committee of Istanbul Educational and Research Hospital (2011-KAEK-50).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}